Tamás Molnár

21PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Horticultural crop protection (incl. pests, diseases and weeds)Predictive and prognostic markersAutoimmunityMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.

Uria Shani, Monica State, Radu Bogdan Mateescu

|Oct 29, 2024
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real-Life Retrospective Multicentre Cohort Study.

Péter Bacsur, Daniel Shaham, Zuzana Serclova

|Aug 06, 2024
Translational evaluation of Gelsectan® effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhoea.

Orsolya Inczefi, Hélène Eutamene, Fanny Placide

|Sep 26, 2023
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.

Boldizsár Jójárt, Tamás Resál, Diána Kata

|May 10, 2023
Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey.

Patrícia Sarlós, Alexander Bikar, Nelli Farkas

|Feb 22, 2023
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone.

Tamás Resál, Katalin Mangó, Péter Bacsur

Pageof 4

Frequent Collaborators

13 joint publications

Tamás Molnár

11 joint publications

Anita Bálint

11 joint publications

Anna Fábián

10 joint publications

Zoltán Szepes